P. Janssen

发表

Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity

P. Lewi, H. Moereels, K. Andries, 1990, Journal of virology.

New [4,5,1-JK][1,4]benzodiazepin-2(1H)-one and -thione derivatives are potent inhibitors of human immunodeficiency virus type 1 and are synergistic with 2',3'-dideoxynucleoside analogs

R. Pauwels, E. Clercq, Z. Debyser, 1994 .

The antiinflammatory effects of ketoconazole. A comparative study with hydrocortisone acetate in a model using living and killed Staphylococcus aureus on the skin of guinea-pigs.

F. Odds, J. V. van Cutsem, P. Janssen, 1991, Journal of the American Academy of Dermatology.

(Fe)male? How contaminants can disrupt the balance of sex hormones and affect reproduction in terrestrial wildlife species

A. Bosveld, J. Faber, P. Janssen, 1998 .

The effects of methyl (5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl) carbamate, (R 17934; NSC 238159), a new synthetic antitumoral drug interfering with microtubules, on mammalian cells cultured in vitro.

M. De Brabander, M. Borgers, P. Janssen, 1976, Cancer research.

Environmental pollution caused elevated concentrations of oestradiol and vitellogenin in the female flounder, Platichthys flesus (L.)

P. Janssen, A. Vethaak, P. Janssen, 1997 .

The annual ovarian cycle and the influence of pollution on vitellogenesis in the flounder, Pleuronectes flesus

P. Janssen, P. Janssen, H. Goos, 1995 .

Intranasal pirodavir (R77,975) treatment of rhinovirus colds

F. Hayden, K. Andries, G. Hipskind, 1995, Antimicrobial agents and chemotherapy.

Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection

F. Hayden, K. Andries, P. Janssen, 1992, Antimicrobial Agents and Chemotherapy.

In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity

K. Andries, J. Snoeks, R. Willebrords, 1992, Antimicrobial Agents and Chemotherapy.

Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837)

D. Tyrrell, K. Andries, W. Al-Nakib, 1989, Antimicrobial Agents and Chemotherapy.

An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives.

E. De Clercq, R. Pauwels, Z. Debyser, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Cerebroprotective effects of flunarizine in an experimental rat model of cardiac arrest.

H. R. Lu, J. van Reempts, M. Borgers, 1990, The American journal of emergency medicine.

Itraconazole penetrates the nail via the nail matrix and the nail bed—an investigation in onychomycosis

R. Woestenborghs, P. Janssen, V. Velde, 1991, Clinical and experimental dermatology.

Experimental cryptococcosis: dissemination of Cryptococcus neoformans and dermotropism in guinea-pigs.

J. V. van Cutsem, P. Janssen, J. Fransen, 1986, Mykosen.

New antihistaminic N-heterocyclic 4-piperidinamines. 3. Synthesis and antihistaminic activity of N-(4-piperidinyl)-3H-imidazo[4,5-b]pyridin-2-amines.

F. Janssens, M. Janssen, P. Janssen, 1985, Journal of medicinal chemistry.

New antihistaminic N-heterocyclic 4-piperidinamines. 2. Synthesis and antihistaminic activity of 1-[(4-fluorophenyl)methyl]-N-(4-piperidinyl)-1H-benzimidazol-2-a mines.

F. Janssens, M. Janssen, P. Janssen, 1985, Journal of medicinal chemistry.

New antihistaminic N-heterocyclic 4-piperidinamines. 1. Synthesis and antihistaminic activity of N-(4-piperidinyl)-1H-benzimidazol-2-amines.

F. Janssens, M. Janssen, P. Janssen, 1985, Journal of medicinal chemistry.

Treatment of experimental zygomycosis in guinea pigs with azoles and with amphotericin B.

J. V. van Cutsem, P. Janssen, J. Fransen, 1989, Chemotherapy.

Itraconazole compared with griseofulvin in the treatment of tinea corporis/cruris and tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile.

J. Lachapelle, D. Tennstedt, P. Janssen, 1992, Dermatology.

Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models.

J. V. van Cutsem, P. Janssen, F. van Gerven, 1987, Reviews of infectious diseases.

Ketoconazole — a new broad spectrum orally active antimycotic

J. Heeres, P. Janssen, J. Cutsem, 1979, Experientia.

Oral treatment with ketoconazole in systemic candidosis of guinea-pigs: microbiology, hematology and histopathology.

J. V. van Cutsem, P. Janssen, J. Fransen, 1985, Sabouraudia.

Histopathology of experimental systemic candidosis in guinea-pigs.

J. V. van Cutsem, P. Janssen, J. Fransen, 1984, Sabouraudia.

Experimental systemic dermatophytosis.

J. V. van Cutsem, P. Janssen, 1984, The Journal of investigative dermatology.

Itraconazole, a new triazole that is orally active in aspergillosis

J. V. van Cutsem, M. Borgers, P. Janssen, 1984, Antimicrobial Agents and Chemotherapy.

Experimental Zygomycosis Due to Rhizopus spp. Infection by Various Routes in Guinea‐Pigs, Rats and Mice

P. Janssen, J. Cutsem, J. Fransen, 1988, Mycoses.

Terconazole - a new broad-spectrum antifungal.

J. V. van Cutsem, P. Janssen, F. van Gerven, 1983, Chemotherapy.

Oral and parenteral therapy with saperconazole (R 66905) of invasive aspergillosis in normal and immunocompromised animals

J. V. van Cutsem, P. Janssen, F. van Gerven, 1989, Antimicrobial Agents and Chemotherapy.

The in vitro antifungal activity of ketoconazole, zinc pyrithione, and selenium sulfide against Pityrosporum and their efficacy as a shampoo in the treatment of experimental pityrosporosis in guinea pigs.

J. V. van Cutsem, P. Janssen, J. Fransen, 1990, Journal of the American Academy of Dermatology.

SAPERCONAZOLE, A NEW POTENT ANTIFUNGAL TRIAZOLE: IN VITRO ACTIVITY SPECTRUM AND THERAPEUTIC EFFICACY

P. Janssen, J. Cutsem, F. Gerven, 1989 .

Therapeutic efficacy of itraconazole in systemic candidosis in guinea pigs.

J. V. van Cutsem, P. Janssen, J. Fransen, 1987, Chemotherapy.

The levamisole story.

P. Janssen, 1976, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats.

M. Borgers, J Van Reempts, M Borgers, 1989, Stroke.

Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediators

C. Niemegeers, K. Schellekens, M. Borgers, 1977, Experientia.

Morphological evaluation of oxatomide--a new anti-allergic drug in guinea pig anaphylaxis.

M. De Brabander, M. Borgers, F. Awouters, 1978, International archives of allergy and applied immunology.

New Antihistaminic N-Heterocyclic 4-Piperidinamines. Part 3. Synthesis and Antihistaminic Activity of N-(4-Piperidinyl)-3H-imidazo[4,5-b]pyridin-2-amines.

F. Janssens, M. Janssen, P. Janssen, 1986 .

In vitro activity of R 61837, a new antirhinovirus compound

M. De Brabander, K. Andries, B. Dewindt, 2005, Archives of Virology.

Allosteric inhibition of human immunodeficiency virus type 1 reverse transcriptase by tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione compounds.

E. De Clercq, R. Pauwels, Z. Debyser, 1992, Molecular Pharmacology.